Inventor · disambiguated record
Kevin Friedman
Also filed as: FRIEDMAN KEVIN · FRIEDMAN KEVIN M · FRIEDMAN KEVIN W
24 granted patents·16 pending applications·212 citations·filing 2005–2025
96Inventor score
Files with2SEVENTY BIO INC18BLUEBIRD BIO INC11KELONIA THERAPEUTICS INC7REGENERON PHARMA2FRIEDMAN KEVIN W1
Top patents by PatentIndex Score
40 records- 0197US11020466B2BCMA chimeric antigen receptorsBLUEBIRD BIO INC·Filed 2020·Granted Jun 1, 2021·17 cites·27 claims
- 0296US11382965B2BCMA chimeric antigen receptors2SEVENTY BIO INC·Filed 2020·Granted Jul 12, 2022·6 cites·30 claims
- 0396US11351236B2BCMA chimeric antigen receptors2SEVENTY BIO INC·Filed 2020·Granted Jun 7, 2022·7 cites·39 claims
- 0496US10383929B2BCMA chimeric antigen receptorsBLUEBIRD BIO INC·Filed 2015·Granted Aug 20, 2019·29 cites·21 claims
- 0595US11633463B2BCMA chimeric antigen receptors2SEVENTY BIO INC·Filed 2020·Granted Apr 25, 2023·4 cites·24 claims
- 0695US10646558B2BCMA chimeric antigen receptorsBLUEBIRD BIO INC·Filed 2019·Granted May 12, 2020·19 cites·30 claims
- 0795US10639359B2BCMA chimeric antigen receptorsBLUEBIRD BIO INC·Filed 2019·Granted May 5, 2020·19 cites·21 claims
- 0895US10639358B2BCMA chimeric antigen receptorsBLUEBIRD BIO INC·Filed 2019·Granted May 5, 2020·19 cites·30 claims
- 0995US10624960B2BCMA chimeric antigen receptorsBLUEBIRD BIO INC·Filed 2019·Granted Apr 21, 2020·19 cites·15 claims
- 1095US10479975B2Methods of making T cell compositionsBLUEBIRD BIO INC·Filed 2015·Granted Nov 19, 2019·28 cites·21 claims
- 1194US12312593B2Lymphocyte targeted lentiviral vectorsKELONIA THERAPEUTICS INC·Filed 2023·Granted May 27, 2025·3 cites·10 claims
- 1293US10774343B2MND promoter chimeric antigen receptorsBLUEBIRD BIO INC·Filed 2015·Granted Sep 15, 2020·21 cites·11 claims
- 1392US12269882B1Antigen binding polypeptidesKELONIA THERAPEUTICS INC·Filed 2024·Granted Apr 8, 2025·3 cites·30 claims
- 1492US12029784B2BCMA chimeric antigen receptors2SEVENTY BIO INC·Filed 2020·Granted Jul 9, 2024·2 cites·50 claims
- 1592US11560547B2Methods of making T cell compositions2SEVENTY BIO INC·Filed 2019·Granted Jan 24, 2023·5 cites·38 claims
- 1690US12440564B2Compositions for treating cancerKELONIA THERAPEUTICS INC·Filed 2024·Granted Oct 14, 2025·1 cites·25 claims
- 1789US11479755B2T cell compositions2SEVENTY BIO INC·Filed 2015·Granted Oct 25, 2022·5 cites·19 claims
- 1889US2025026845A1Bcma chimeric antigen receptors2SEVENTY BIO INC·Filed 2024·Application pending·0 cites
- 1987US12006369B2BCMA chimeric antigen receptors2SEVENTY BIO INC·Filed 2019·Granted Jun 11, 2024·2 cites·32 claims
- 2083US12403194B2Compositions for treating cancerKELONIA THERAPEUTICS INC·Filed 2024·Granted Sep 2, 2025·0 cites·25 claims
- 2180US12060419B2CD79A chimeric antigen receptorsREGENERON PHARMA·Filed 2019·Granted Aug 13, 2024·1 cites·20 claims
- 2279US2024417481A1Bcma chimeric antigen receptors2SEVENTY BIO INC·Filed 2024·Application pending·0 cites
- 2377US12247084B2Anti-BCMA CAR antibodies, conjugates, and methods of use2SEVENTY BIO INC·Filed 2019·Granted Mar 11, 2025·1 cites·14 claims
- 2477US2023193202A1Methods for making t cell compositions2SEVENTY BIO INC·Filed 2022·Application pending·0 cites
- 2577US2024401080A1Mnd promoter chimeric antigen receptors2SEVENTY BIO INC·Filed 2024·Application pending·0 cites
- 2676US2025257129A9Cd79a chimeric antigen receptorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 2774US2025277238A1Lymphocyte targeted lentiviral vectorsKELONIA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2871US12435140B2Antigen binding polypeptidesKELONIA THERAPEUTICS INC·Filed 2025·Granted Oct 7, 2025·0 cites·30 claims
- 2971US11279769B2Anti-Sialyl Tn chimeric antigen receptorsHELIXMITH CO LTD·Filed 2016·Granted Mar 22, 2022·1 cites·25 claims
- 3070US2024218390A1Lymphocyte targeted lentiviral vectorsKELONIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3164US2021032658A1Mnd promoter chimeric antigen receptorsBLUEBIRD BIO INC·Filed 2020·Application pending·0 cites
- 3262US2025290041A1Methods for manufacturing adoptive cell therapies2SEVENTY BIO INC·Filed 2025·Application pending·0 cites
- 3359US2025197523A1Anti-bcma car antibodies, conjugates, and methods of use2SEVENTY BIO INC·Filed 2025·Application pending·0 cites
- 3452US2022280567A1Compositions and methods for treating cancer2SEVENTY BIO INC·Filed 2020·Application pending·0 cites
- 3551US2022195060A1Manufacturing anti-bcma car t cells2SEVENTY BIO INC·Filed 2020·Application pending·0 cites
- 3650US2007150416A1Systems and methods for copy protection during multi-factor authenticating of electronic transactionsFRIEDMAN KEVIN W·Filed 2005·Application pending·0 cites
- 3750US2022226374A1Cd79b chimeric antigen receptors2SEVENTY BIO INC·Filed 2019·Application pending·0 cites
- 3848US12291722B2Methods for manufacturing adoptive cell therapies2SEVENTY BIO INC·Filed 2015·Granted May 6, 2025·0 cites·35 claims
- 3946US2017226216A1Bcma chimeric antigen receptorsBLUEBIRD BIO INC·Filed 2015·Application pending·0 cites
- 4034US2017049819A1Kappa/lambda chimeric antigen receptorsBLUEBIRD BIO INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin Friedman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →